The effects of a soy rich diet on serum lipids: the Menfis randomized trial

被引:32
作者
Chiechi, LM
Secreto, G
Vimercati, A
Greco, P
Venturelli, E
Pansini, F
Fanelli, M
Loizzi, P
Selvaggi, L
机构
[1] Univ Bari, Dept Obstet & Gynaecol, I-70125 Bari, Italy
[2] Natl Canc Inst, I-20133 Milan, Italy
[3] Policlin Bari, Dept Anal, Bari, Italy
[4] Univ Bari, Dept Med Stat, Bari, Italy
关键词
soy; lipid profile; cardiovascular health; menopause; phytoestrogens;
D O I
10.1016/S0378-5122(01)00259-6
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To assess beneficial effects of a soy rich diet on the main biomarkers of cardiovascular health in menopause. compared with the effects of the hormone replacement therapy (HRT). Methods: 187 healthy asymptomatic postmenopausal women, aged 39-60. were recruited and randomized into three groups: a soy rich diet group, a HRT group, and a control group. Lipid profile, body mass index, blood pressure. endometrial thickness, uterine artery resistance index (RI), were evaluated in all the participants at the baseline, after 6 months, and at the end of the study. Results: After a 6-month intervention period. the lipid profile in the soy rich diet group showed a favourable outcome, similar to that observed in the HRT group, but compliance to the diet was low. Conclusion: Soy, products may be used in the prevention of cardio vascular risk in postmenopausal women because of their efficacy in contrasting the negative effects of menopause on the cardiovascular system, but our findings should be confirmed; moreover. suitable strategies to improve the compliance have to be considered. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 38 条
[1]   METAANALYSIS OF THE EFFECTS OF SOY PROTEIN-INTAKE ON SERUM-LIPIDS [J].
ANDERSON, JW ;
JOHNSTONE, BM ;
COOKNEWELL, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05) :276-282
[2]  
[Anonymous], 1974, NEW ENGL J MED, V290, P15
[3]  
AVILA MH, 1990, EPIDEMIOLOGY, V1, P128
[4]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[5]  
Berrino F, 2001, CANCER EPIDEM BIOMAR, V10, P25
[6]   DIFFERENCES IN LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND APOLIPOPROTEINS IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN [J].
CAMPOS, H ;
MCNAMARA, JR ;
WILSON, PWF ;
ORDOVAS, JM ;
SCHAEFER, EJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) :30-35
[7]  
CASSIDY A, BIOL EFFECTS ISOFLAV
[8]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[9]   THE TRIGLYCERIDE ISSUE - A VIEW FROM FRAMINGHAM [J].
CASTELLI, WP .
AMERICAN HEART JOURNAL, 1986, 112 (02) :432-437
[10]   Inhibition of postmenopausal atherosclerosis progression: A comparison of the effects of conjugated equine estrogens and soy phytoestrogens [J].
Clarkson, TB ;
Anthony, MS ;
Morgan, TM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :41-47